Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

JOINN Bio Raises $60 Million for US-China Biologic CDMO Operations

publication date: Dec 11, 2019

JOINN Biologics, a US-China biologics CDMO, raised $60 million in a Series A financing led by Huagai Capital, a private equity firm. JOINN Biologics was founded in 2018 as the biologics subsidiary of JOINN Laboratories, a China CRO based in Suzhou and Beijing. JOINN Bio is headquartered in a San Francisco-area building that JOINN Labs acquired in 2013. The company said it would use the proceeds from the funding to build a 100,000-liter production base in Beijing and expand its biologics business in China and the US. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital